drugset
drugset / Trial / NCT05809271

Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) With and Without a Booster Dose

NCT05809271 ↗

Phase 1 Completed 25 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverTriple-blindBasic science

Summary

3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. The current study investigates differences in duration of acute effects and side effects after administration of a single dose of MDMA compared to a repeated administration.

Timeline

Start
2023-11-17
Primary completion
2025-03-07
Completion
2025-03-07

Drugs

EvaluationDrugModalityDoseRoute
Subject MDMA Unknown 60 mg Oral
Subject MDMA Unknown 120 mg Oral

Indications

No indication recorded.